RESEARCH/NEWS

At Bisep Innovations, our dedication to advancing patient mobility is supported by rigorous research and testing. Our clinical trials and focus groups validate the effectiveness of the ARMM device in improving walking speed, distance, and confidence while reducing the fear of falling. These studies, conducted with renowned healthcare institutions, reinforce our commitment to providing innovative and reliable mobility solutions.

Clinical trial results

24%

Increase in Walking Speed

Research has demonstrated that the Arise Walking System increases patients' walking speed by 24%. Users who utilized the ARMM device walked 24% faster compared to those employing the traditional method, in which a therapist follows behind with a wheelchair.

15%

Increase in Walking Distance

Research has shown that the Arise Walking System enables patients to improve their walking distance by 15%. Users who walked with the ARMM device achieved a 15% greater walking distance compared to those using the traditional method, where a therapist follows behind with a wheelchair.

48%

Boost in Self-Confidence

Research indicates that the Arise Walking System significantly enhances patients' walking self-confidence by 48%. Users who utilized the ARMM device reported a 48% increase in walking self-confidence compared to those using the traditional approach, in which a therapist follows behind with a wheelchair.

24%

Reduction in Fear of Falling

Research has shown that the Arise Walking System effectively reduces patients' fear of falling by 20%. Users who walked with the ARMM device reported a 20% reduction in fear of falling compared to those who utilized the traditional method, where a therapist follows behind with a wheelchair.

Clinical Trials

Clinical Trial 1: Enhancing Patient Mobility at Niagara Health Long Term Care Homes

In partnership with Brock University, BISEP conducted a clinical trial at various Niagara Health Long Term Care Homes to evaluate the ARMM device’s impact on patient mobility. The trial demonstrated significant improvements in walking safety, ambulation training, and patient outcomes, reducing fall risks and enhancing overall quality of life.

Clinical Trial 2: Workflow Implementation at Perley Health

This study, led by the University of Ottawa with AGE-WELL funding, focused on integrating the ARMM device into Perley Health's physiotherapy practices. The trial showed improved workflow efficiency, with positive feedback from both therapists and residents regarding the device's effectiveness and ease of use.

Clinical Trial 3: Feedback and Workflow Integration at Juravinski Hospital

At Juravinski Hospital in Hamilton, Bisep Innovations held a focus group with over 30 physiotherapists to gather feedback on the ARMM device. The group provided valuable insights into the device's functionality, leading to further refinements and confirming its potential as an essential tool in physiotherapy practices.

Research partners

Manufacturing

BISEP has implemented large-scale manufacturing processes backed by strict quality control and safety testing, ensuring that our products meet the highest standards of safety and durability. Our manufacturer has ISO 13485, ISO 9001, SGS Certification, and adheres to Good Manufacturing Practices (GMP), including full traceability and recall procedures.

Keep up to date with the latest medical, rehabilitation, aging news, as well as BISEP company updates.

Who can benefit from the ARMM?

From healthcare to your home!

ORGANIZATIONS

INDIVIDUALS

In the news

Featured In

Title

What Our Customers Are Saying

"BISEP’s ARMM Device is a groundbreaking solution that’s transforming the way we approach patient mobility and rehabilitation. By improving mobility, reducing fall risks, and delivering cost savings across the healthcare system, it creates measurable impact. I highly recommend the ARMM device. It's an invaluable asset for any healthcare organization focused on safe ambulatory therapy."

Bob Bell Former Deputy Minister of Health and Long-Term Care, Province of Ontario